within Pharmacolibrary.Drugs.ATC.V;

model V10XX04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.19 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 7400 / 1000000,
    adminCount     = 1,
    Vd             = 0.018,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Lutetium (177Lu) oxodotreotide is a radiolabeled somatostatin analog used in peptide receptor radionuclide therapy (PRRT) for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). It binds to somatostatin receptors overexpressed on tumor cells, allowing targeted delivery of beta-radiation. Approved for clinical use, notably as Lutathera.</p><h4>Pharmacokinetics</h4><p>Population pharmacokinetics in adult patients with advanced, progressive, somatostatin receptor-positive GEP-NETs after intravenous administration.</p><h4>References</h4><ol><li><p>Thakral, P, et al., &amp; Malik, D (2021). Dosimetric analyses of intra-arterial versus standard intravenous administration of 177Lu-DOTATATE in patients of well differentiated neuroendocrine tumor with liver-dominant metastatic disease. <i>The British journal of radiology</i> 94(1126) 20210403–None. DOI:<a href=&quot;https://doi.org/10.1259/bjr.20210403&quot;>10.1259/bjr.20210403</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34357794/&quot;>https://pubmed.ncbi.nlm.nih.gov/34357794</a></p></li><li><p>Barakat, A, et al., &amp; Khier, S (2023). Clinical Pharmacokinetics of Radiopharmaceuticals from SPECT/CT Image Acquisition by Contouring in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Lu-177 DOTATATE (Lutathera. <i>European journal of drug metabolism and pharmacokinetics</i> 48(4) 329–339. DOI:<a href=&quot;https://doi.org/10.1007/s13318-023-00829-5&quot;>10.1007/s13318-023-00829-5</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37184824/&quot;>https://pubmed.ncbi.nlm.nih.gov/37184824</a></p></li><li><p>Schmitt, A, et al., &amp; Forssell-Aronsson, E (2004). Radiation therapy of small cell lung cancer with 177Lu-DOTA-Tyr3-octreotate in an animal model. <i>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</i> 45(9) 1542–1548. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15347722/&quot;>https://pubmed.ncbi.nlm.nih.gov/15347722</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end V10XX04;
